Used primarily as an active pharmaceutical ingredient in the treatment of type 2 diabetes. It functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promoting the excretion of glucose through the urine by blocking its reabsorption in the kidneys. This helps lower blood glucose levels in adults with diabetes. The compound contributes to improved glycemic control and may also support weight loss and blood pressure reduction due to its mechanism of action. It is typically administered orally in tablet form and is often prescribed as part of a broader diabetes management plan that includes diet and exercise.